ALPHA-1 ANTI-TRYPSIN MODULATORS

VE6142019000563SUndetermined Publication Date: 2022-02-17VERTEX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
VE · VE
Patent Type
Designs
Current Assignee / Owner
VERTEX PHARMACEUTICALS INC
Filing Date
2019-10-07
Publication Date
2022-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

NEW COMPOUNDS, COMPOSITIONS AND METHODS OF USE AND PREPARATION THEREOF, WHICH MAY BE USEFUL IN THE TREATMENT OF ALPHA-1 ANTI-TRYPSIN DEFICIENCY (AATD).